logo

Beacon at a glance

Beacon Pharmaceuticals PLC is a renowned pharmaceutical company in Bangladesh that came to light for its innovative treatment approaches towards the betterment of the quality of life. Beacon was established as a company in 2006 and became a Public Limited Company in 2010. Through continuous research and development, the company ensures providing innovative pharmaceutical solutions to the people of Bangladesh and the world at large, thus ensuring stakeholders' satisfaction.

The pharmaceutical company manufactures anti-cancer, cardiovascular, gastrointestinal drugs in addition to antibiotics, anti-coagulants, protein supplements, muscle relaxants, antihistamines, analgesics, NSAIDS, and more. Hence, it ensures the image of launching unique products and the fastest-growing medicine industry in Bangladesh.

The state-of-the-art manufacturing plant is located at Bhaluka, Mymensingh, Bangladesh covers 30 acres of land area. The European experts who designed this Beacon industrial facility made it one of the best in the nation. It is made to meet international standards set by organizations like the WHO-CGMP, US FDA, UK MHRA, TGA, and Australia.

It is also a matter of great pride for BEACON that the company has achieved the prestigious EU GMP certificate for its dedicated Cephalosporin facility.

Road to Success

Our milestones are a reflection of our commitment to the future.

  • 2006
    Started of commercial operation
  • 2008
    Appeared as public limited company
  • 2009
    Initiated manufacturing anti-cancer medicines for the first time in Bangladesh
  • 2011
    Introduced Bio-tech products for the first time in Bangladesh
  • 2012
    Exported the life saving anticancer products for the first time in Bangladesh
  • 2015
    Introduced anti-hepatitis-C product for the first time in Bangladesh
  • 2020
    Begun the journey of cephalosporin & Introduced life-saving Favipira & Pandovir for the COVID infected patients
  • 2021
    Started a new project of capsule shell
  • 2022
    First oral erythropoietic drug introduction and nation wide much awareness creation on thalassemia.

Guiding Principles

Guiding Principles

Our mission

To improve the quality of human life by providing innovative pharmaceutical products developed through continuous research and development ensuring stakeholders satisfaction.

Our Vision

To be regarded and recognized as one of the most value-driven pharmaceuticals companies in the country.

Core Values

01

Commitment

Committed to quality in all our activities

01

Believe

Believe in winning

01

Trust

Trustworthy relationship with customer

01

Innovation

Encourage innovative ideas

01

Respect

Respect to other

01

Responsibility

Corporate social responsibility

01

Team

Work as a team